1. Market Research
  2. > Biotechnology
  3. > Genomics Market Trends
Cancer Biomarkers Market by Type, Cancer Type, Profiling Technology, Application - Global Forecast to 2022

Cancer Biomarkers Market by Type, Cancer Type, Profiling Technology, Application - Global Forecast to 2022

  • October 2017
  • 251 pages
  • ID: 5139366
In this report:
According to OECD, a total of ##,## new cancer cases (excluding nonmelanoma skin cancer) were reported in 2012, and this number is expected to reach ##,## by 2020, representing an increase of ##%.
The global cancer biomarkers market was valued at USD ##.## billion in 2017, and is expected to record a CAGR of ##.##% during the forecast period, to reach USD ##.## billion by 2022.

Summary

Table of Contents

Search Inside

Global cancer biomarkers market projected to grow at CAGR of 12.2%
The global cancer biomarkers market is projected to reach USD 20.48 billion by 2022 from USD 11.53 billion in 2017, at a CAGR of 12.2% from 2017 to 2022.
Over the years, the cancer biomarkers market has evolved significantly owing to the rising prevalence of cancer, advancements in omics technologies, increasing healthcare expenditure, growth in R&D funding from government and private bodies, and rising demand for personalized medicine in cancer therapies. However, an unfavorable regulatory and reimbursement scenario and the high capital investments required for biomarker development and validation are some factors expected to restrain the market.

The lung cancer segment is expected to register the highest CAGR’

The cancer biomarkers market on the basis of cancer type is classified into breast, lung, colorectal, prostate, melanoma, leukemia, thyroid, bladder, non-hodgkin’s lymphoma, kidney, and other cancers.The lung cancer segment is expected to register the highest CAGR during the forecast period.

The increasing company focus on research on lung cancer biomarkers is the key driver for this market. Increased understanding of the morphology of lung carcinogenesis, development of the high-throughput techniques for biomarker discovery, and increased focus on early detection of cancer are propelling the growth of this market.

North America is expected to dominate the cancer biomarkers market and APAC growing at the highest CAGR
North America (comprising the US and Canada) is expected to account for the largest share of the global cancer biomarkers market in 2017.The large share of this geographic segment is mainly attributed to the increasing government support for discovery and development of biomarkers, increasing demand for personalized medicine, adoption of advanced omics technologies for biomarker discovery, and rising use of biomarkers in drug discovery and development by pharmaceutical companies in that region.

While the APAC region is expected to register the highest CAGR during the forecast period. The APAC cancer biomarkers market, particularly in China, Japan, and India is expected to witness high growth during the forecast period.

Break of primary participants was as mentioned below:
• By Company Type – Tier 1–40%, Tier 2–30%, and Tier 3–30%
• By Designation – Director level–18%, C-Level–27%, and Others–55%
• By Region – North America–50%, Europe–20%, Asia-Pacific–20%, and RoW–10%

Major players in this market that are profiled in the report includes Abbott (US), Affymetrix (US), Roche (Switzerland), Illumina (US), QIAGEN (Netherlands), Agilent (US), Thermo Fisher (US), Merck (US), Becton Dickinson (US), Hologic (US), Danaher (US), and Shimadzu (Japan).

Research Coverage:
From an insight perspective, this research report focuses on qualitative data, market size, and growth of various segments and subsegments, competitive landscape, and company profiles.The qualitative data covers various levels of industry analysis such as market dynamics (drivers, restraints, opportunities, and challenges).

The report also offers market sizes and data on the growth of various segments of the industry.It focuses on emerging and high-growth segments, and high-growth regions.

The competitive landscape covers growth strategies adopted by industry players in the last three years.The company profiles comprise basic views on key players in the cancer biomarkers market and the product portfolios, developments, and strategies adopted by market players to maintain and increase their market shares in the near future.

The above-mentioned market research data, current market size, and forecast of future trends will help key players and new entrants to make the necessary decisions regarding product offerings, geographical focus, change in approach, R&D investments for innovations in products and technologies, and levels of output to remain successful.

Reasons to buy this report:
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help garner a greater share. Firms purchasing the report could use one or any combination of the below-mentioned five strategies.

The report provides insights on the following pointers:
• Market Penetration: Comprehensive information on products offered by the top players in the cancer biomarkers market
• Product/Service Enhancement/Innovation: Detailed insights on the upcoming technologies, research & development activities, and new product launches in the cancer biomarkers market
• Market Development: Comprehensive information about lucrative emerging markets—the report analyzes the markets for profiling technologies across various regions
• Market Diversification: Exhaustive information about new products, untapped geographies, and recent developments in the cancer biomarkers market
• Competitive Assessment: In-depth assessment of market ranking, strategies, products, and manufacturing capabilities of the leading players in the cancer biomarkers market

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
2019-2023 US Molecular Diagnostic Analyzers and Reagents: Market Share Analysis, Country Segment Forecasts, Competitive Intelligence, Technology Trends, Opportunities for Suppliers

2019-2023 US Molecular Diagnostic Analyzers and Reagents: Market Share Analysis, Country Segment Forecasts, Competitive Intelligence, Technology Trends, Opportunities for Suppliers

  • $ 3850
  • December 2018

2019-2023 US Molecular Diagnostic Analyzers and Reagents: Market Share Analysis, Country Segment Forecasts, Competitive Intelligence, Technology Trends, Opportunities for SuppliersThis new 1,157-page report ...

Global Biotechnology Instrumentation Industry

Global Biotechnology Instrumentation Industry

  • $ 5600
  • January 2019

This report analyzes the worldwide markets for Biotechnology Instrumentation in US$ Thousand by the following Product Segments: DNA Sequencing Systems, DNA Synthesizers, Electrophoresis Systems, Immunoassay ...

2019-2023 France Molecular Diagnostic Analyzers and Reagents: Market Share Analysis, Country Segment Forecasts, Competitive Intelligence, Technology Trends, Opportunities for Suppliers

2019-2023 France Molecular Diagnostic Analyzers and Reagents: Market Share Analysis, Country Segment Forecasts, Competitive Intelligence, Technology Trends, Opportunities for Suppliers

  • $ 2750
  • December 2018

2019-2023 France Molecular Diagnostic Analyzers and Reagents: Market Share Analysis, Country Segment Forecasts, Competitive Intelligence, Technology Trends, Opportunities for SuppliersThis new 1,125-page ...


Download Unlimited Documents from Trusted Public Sources

Biomarker Industry - Forecast

  • September 2018
    38 pages
  • Biomarker  

    Molecular Diagn...  

    In Vitro Diagno...  

  • Europe  

    United States  

    Belgium  

View report >

The future of the Genomics Industry in Canada

  • January 2018
    6 pages
  • Genomics  

  • Canada  

    North America  

View report >

Biomarker Industry - Forecast

  • September 2018
    38 pages
  • Biomarker  

    Molecular Diagn...  

    In Vitro Diagno...  

  • Europe  

    United States  

    Belgium  

View report >

DNA Industry 1 month ago

DNA Industry 2 months ago

Genomics Industry 2 months ago


ref:plp2017

Reportlinker.com © Copyright 2019. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on